查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571749

人工呼吸器/麻醉面罩市場規模、佔有率、趨勢分析報告：按面罩類型、按應用、按地區、細分市場預測，2024-2030 年

Artificial Ventilation And Anesthesia Masks Market Size, Share & Trends Analysis Report By Mask Type (Disposable, Reusable), By Application (Operating Rooms, ICU, Emergency Rooms, Homecare), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

人工呼吸器和麻醉面罩市場的成長和趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球人工呼吸器和麻醉面罩市場預計將達到 33 億美元。預計2024年至2030年該市場將以5.1%的複合年成長率成長。市場成長的關鍵因素包括手術和急救程序數量的增加，以及對無需取下氧氣罩即可進行插管過程的新型產品的需求增加。目標疾病的增加預計將直接影響手術室、急診室和加護治療室的數量，從而推動預測期內呼吸面罩的使用率。

老年人口的增加是多種疾病盛行率增加的主要因素。此外，睡眠呼吸中止症盛行率的增加是預測期內麻醉和呼吸面罩的最重要促進因素之一。

根據美國國家睡眠基金會2012年公佈的統計數據，約有4000萬美國人受到慢性睡眠障礙的影響。此外，這些患者前往急診室和加護病房就診的風險較高，預計未來七年對呼吸面罩的需求將會增加。

根據市場動態，該領域的各個公司在產品規格和價格上競爭。製造中使用的技術、產品品質和患者舒適度是影響這些產品使用的關鍵變數。醫療保健提供者評估患者的風險並決定是否使用有創通氣或非侵入性通氣。在事故、創傷、肺衰竭和其他緊急情況下使用非侵入性口罩是推動這些產品使用增加的一個主要因素。

市場按應用細分為手術室、加護病房、急診室、牙科和居家醫療。 2014年，手術室在低風險手術中所佔比例最大，超過58%，預計在未來七年仍將是最大的部分。保險滲透率的上升、醫院和牙科中心數量的增加，以開拓新興國家未滿足的高需求，是預計推高手術數量的主要因素，因此預計這些因素將增加預測期內對呼吸面罩的需求。增加需求。

人工呼吸器和麻醉面罩市場報告要點

  • 2023年，一次性口罩的銷售佔有率最大，為68.0%。一次性口罩在醫療產業的優勢在於其成本效益、使用者便利性、感染風險降低以及符合法律要求。
  • 手術室應用領域在 2023 年佔據市場主導地位，銷售佔有率為 32.0%。手術室擁有最先進的呼吸系統和麻醉設備，可精確控制空氣循環量和麻醉劑濃度。
  • 預計可重複使用口罩在預測期內將大幅成長，複合年成長率為 4.6%。可重複使用的口罩可以清洗和重複使用，減少廢棄物並最大限度地降低成本，使其成為醫院經濟高效的解決方案。
  • 2023年，北美人工呼吸器/麻醉面罩市場主導全球人工呼吸器/麻醉面罩市場，銷售佔有率為36.1%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章人工呼吸器和麻醉面罩市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 人工呼吸器/麻醉面罩市場分析工具
    • 波特的分析
    • PESTEL分析

第4章：人工呼吸器和麻醉面罩市場：面罩估計和趨勢分析

  • 細分儀表板
  • 人工呼吸器/麻醉面罩市場：面罩波動分析，2023/2030
  • 一次性口罩
  • 可重複使用的口罩

第5章人工呼吸器和麻醉面罩市場：應用估算和趨勢分析

  • 細分儀表板
  • 人工呼吸器/麻醉面罩市場：應用變化分析，2023/2030
  • 手術室
  • 加護病房
  • 急診室
  • 居家醫療
  • ASC

第6章人工呼吸器和麻醉面罩市場：區域估計和趨勢分析

  • 2023年及2030年人工呼吸器和麻醉面罩按地區市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • GaleMed Corporation.
    • Dragerwerk AG & Co. KGaA
    • BD
    • Air Liquide Medical Systems
    • Koninklijke Philips NV
    • ResMed
    • Ambu A/S
    • VYAIRE MEDICAL, INC.
    • NIHON KOHDEN CORPORATION
    • Hamilton Medical
    • Thermo Fisher Scientific Inc.
    • Medtronic
簡介目錄
Product Code: 978-1-68038-709-4

Artificial Ventilation And Anesthesia Masks Market Growth & Trends:

The global artificial ventilation and anesthesia masks market size is anticipated to reach USD 3.30 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.1% from 2024 to 2030. Key factors attributing to market growth include rising number of operation and emergency room procedures coupled with growing demand novel products which can be used to carry out intubation process without removing the oxygen mask. Increase in the target disease has a direct impact on the number of operation room, emergency and intensive care procedures and is expected to boost usage rates of ventilation masks over the forecast period.

Increasing geriatric population is a major factor increasing the prevalence rate of several diseases. Additionally, growing prevalence of sleep apnea is one of the most significant growth drivers for these anesthesia and ventilation masks over the forecast period.

According to statistics published by the National Sleep Foundation in 2012, around 40 million Americans were affected by chronic sleep disorders. Furthermore, these patients are at a high risk of visiting emergency department and intensive care units, and as a consequence are expected to increase the demand of ventilation masks in the next seven years.

The market dynamics indicate that various players operating in this space compete on the basis of product specification and prices. The technology used to manufacture, quality of the product, and patient comfort are the key variables expected to impact the usage of these products. The healthcare providers assess the risk to the patient and determine the need to use invasive ventilation or non-invasive ventilation. The use of non invasive masks in accident and trauma cases, lung failure and other emergency cases is a key factor contributing to the high usage rates of these products.

The market is segmented on the basis of application as operation room, intensive care units, emergency room, dental, and home care. In 2014 operating room held the maximum share of over 58% for low risk procedures and is expected to be the largest segment in the next seven years. Increase in insurance penetration, number of hospitals and dental centers to tap the high unmet needs in emerging economies is a key factor expected to boost the surgical volume and therefore these factors are expected to increase the demand for ventilation masks over the forecast period.

Artificial Ventilation And Anesthesia Masks Market Report Highlights:

  • Disposable masks accounted for the largest revenue share of 68.0% in 2023. The dominance of disposable masks in the medical industry is driven by their cost-effectiveness, user convenience, reduced infection risk, and adherence to legal requirements.
  • The operating rooms application segment dominated the market with a revenue share of 32.0% in 2023. Operating rooms have modern working ventilation systems and devices for anesthesia where one is able to control in detail the amount of air circulation and the concentration of the anesthetic mixture.
  • Reusable masks are expected to grow significantly over the forecast period, registering a CAGR of 4.6%. Reusable masks offer a cost-effective solution for hospitals, as they can be cleaned and reused, reducing waste and minimizing costs.
  • North America artificial ventilation and anesthesia masks market dominated the global artificial ventilation and anesthesia masks market with a revenue share of 36.1% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Ventilation and Anesthesia Masks Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Artificial Ventilation and Anesthesia Masks Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Artificial Ventilation and Anesthesia Masks Market: Masks Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Artificial Ventilation and Anesthesia Masks Market: Masks Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Disposable Masks
    • 4.3.1. Disposable Masks Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Reusable Masks
    • 4.4.1. Reusable Masks Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Artificial Ventilation and Anesthesia Masks Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Operating Rooms
    • 5.3.1. Operating Rooms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. ICU
    • 5.4.1. ICU Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Emergency Rooms
    • 5.5.1. Emergency Rooms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Homecare
    • 5.6.1. Homecare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. ASCs
    • 5.7.1. ASCs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Artificial Ventilation and Anesthesia Masks Market: Regional Estimates & Trend Analysis

  • 6.1. Artificial Ventilation and Anesthesia Masks Market Share, By Region, 2023 & 2030 (USD Billion)
  • 6.2. North America
    • 6.2.1. North America Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.2. UK
      • 6.3.2.1. UK Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4. France
      • 6.3.4.1. France Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. China
      • 6.4.2.1. China Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. India
      • 6.4.4.1. India Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. GaleMed Corporation.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Dragerwerk AG & Co. KGaA
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. BD
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Air Liquide Medical Systems
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Koninklijke Philips N.V.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. ResMed
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Ambu A/S
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. VYAIRE MEDICAL, INC.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. NIHON KOHDEN CORPORATION
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. Hamilton Medical
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. Thermo Fisher Scientific Inc.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. Medtronic
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives